EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early experience on injectable micronized putty type human‐derived acellular dermal matrix ( ADM ) in management of diabetic foot wounds in Singapore

Alison Mei Fern Quah, Marcus Jia Ming Ng, Li Zhang, Yam Meng Chan iD, Shufen Neo, Malcolm Mak iD, Qiantai Hong iD, Glenn Tan, Ying Pan, Enming Yong iD

International Wound Journal · 2025

DOI: 10.1111/iwj.70127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Wound Journal, 2025. Verfasst von Alison Mei Fern Quah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery Unit, Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore. Hauptthemen laut MEDLINE: Diabetic Foot, Acellular Dermis, Wound Healing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic foot wounds (DFW) are notoriously difficult to treat owing to poor vascularity, delayed healing and higher rates of infection. Human‐derived acellular dermal matrices (ADM) have been used in DFW treatment, utilizing a matrix scaffold for new tissue generation. We investigate the efficacy of a micronized injectable human‐derived ADM in the treatment of DFW. We retrospectively recruited 13 patients with diabetic foot wounds. Wounds were adequately debrided, and a micronized injectable ADM was applied. Wound sizes were recorded prior to treatment, at 2 and 4 weeks post‐treatment. The mean defect of wounds treated was 19.21 cm 3 . Our results showed a statistically significant reduction in wound size of 45% and 59% at 2 and 4 weeks post‐treatment, respectively ( p < 0.01). ADM was also effective in infected DFW as 84% of our wounds had positive tissue cultures at the time of application. Micronized injectable ADM has proven to be an effective treatment for DFW. Advantages include a ready‐to‐use injectable, single‐stage treatment, minimal pain, mouldable matrix to fit any wound shape, allows for outpatient treatment and simple wound dressings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic FootAcellular DermisWound HealingHumansMaleFemaleRetrospective StudiesMiddle AgedAgedSingaporeTreatment OutcomeAdultDebridementAged, 80 and over

Stichwörter der Autor:innen

acelluar dermal matrixdiabetic foot woundslower limb woundspasteputty matrixwound healing

Autor:innen und Institutionen

  • Vascular Surgery Unit, Department of General Surgery, Tan Tock Seng Hospital, Singapore, Singapore.
  • Skin Research Institute of Singapore, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.

ORCID-Profile: Yam Meng Chan, Malcolm Mak, Qiantai Hong, Enming Yong

Zitieren

APA

Quah, A. M. F., Ng, M. J. M., Zhang, L., Chan, Y. M., Neo, S., Mak, M., Hong, Q., Tan, G., Pan, Y., & Yong, E. (2025). Early experience on injectable micronized putty type human‐derived acellular dermal matrix ( ADM ) in management of diabetic foot wounds in Singapore. International Wound Journal. https://doi.org/10.1111/iwj.70127

Vancouver

Quah AMF, Ng MJM, Zhang L, Chan YM, Neo S, Mak M, et al. Early experience on injectable micronized putty type human‐derived acellular dermal matrix ( ADM ) in management of diabetic foot wounds in Singapore. International Wound Journal. 2025. doi:10.1111/iwj.70127

BibTeX
@article{Quah2025,
  author = {Quah, Alison Mei Fern and Ng, Marcus Jia Ming and Zhang, Li and Chan, Yam Meng and Neo, Shufen and Mak, Malcolm and Hong, Qiantai and Tan, Glenn and Pan, Ying and Yong, Enming},
  title = {Early experience on injectable micronized putty type human‐derived acellular dermal matrix ( ADM ) in management of diabetic foot wounds in Singapore},
  journal = {International Wound Journal},
  year = {2025},
  doi = {10.1111/iwj.70127}
}
Kostenlos starten →